Shares of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) have earned an average recommendation of “Buy” from the eight brokerages that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company. The average twelve-month price […]